153 related articles for article (PubMed ID: 10225729)
1. Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders?
Yamawaki T; Suzuki N
Ther Apher; 1997 Nov; 1(4):348-52. PubMed ID: 10225729
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal antibody elimination in neuroimmunological diseases.
Toepfer M; Schiffl H; Sitter T; Pongratz D; Müller-Felber W
Ther Apher; 1999 Aug; 3(3):268-70. PubMed ID: 10427627
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
[TBL] [Abstract][Full Text] [Related]
4. The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development.
JAMA; 1986 Sep; 256(10):1333-7. PubMed ID: 3747048
[No Abstract] [Full Text] [Related]
5. The utility of therapeutic plasmapheresis for neurological disorders.
Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(4):1-7. PubMed ID: 3537747
[No Abstract] [Full Text] [Related]
6. [Therapeutic plasma exchange for neuroimmunological disorders].
Shibuya N
No To Shinkei; 1993 Oct; 45(10):925-32. PubMed ID: 8268032
[No Abstract] [Full Text] [Related]
7. Plasmapheresis affects T helper type-1/T helper type-2 balance of circulating peripheral lymphocytes.
Goto H; Matsuo H; Nakane S; Izumoto H; Fukudome T; Kambara C; Shibuya N
Ther Apher; 2001 Dec; 5(6):494-6. PubMed ID: 11800088
[TBL] [Abstract][Full Text] [Related]
8. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
Kuwabara S; Nakajima M; Moroo I; Hirayama K
Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682
[TBL] [Abstract][Full Text] [Related]
9. Plasma adsorption in critical care.
Yang KS; Kenpe K; Yamaji K; Tsuda H; Hashimoto H
Ther Apher; 2002 Jun; 6(3):184-8. PubMed ID: 12109940
[TBL] [Abstract][Full Text] [Related]
10. [Plasmapheresis in neurology -- personal experience].
Załeska B; Domzał T; Korsak J
Neurol Neurochir Pol; 1994; 28(2):167-74. PubMed ID: 8047226
[TBL] [Abstract][Full Text] [Related]
11. Plasma exchange in neurology.
Uldry PA; Steck AJ
Curr Stud Hematol Blood Transfus; 1990; (57):167-83. PubMed ID: 2272200
[No Abstract] [Full Text] [Related]
12. Plasma immunoadsorption therapy for Guillain-Barré syndrome: critical day for initiation.
Takei H; Komaba Y; Araki T; Iino Y; Katayama Y
J Nippon Med Sch; 2002 Dec; 69(6):557-63. PubMed ID: 12646988
[TBL] [Abstract][Full Text] [Related]
13. [Plasmapheresis treatment in neurologic diseases--a report of experiences].
Hendrich A; Zschenderlein R; Röseler E; Michalik M; Precht K
Psychiatr Neurol Med Psychol Beih; 1988; 40():79-83. PubMed ID: 3146088
[No Abstract] [Full Text] [Related]
14. [Plasmapheresis in the treatment of acute inflammatory demyelinating polyradiculoneuritis (Guillain-Barre syndrome) (review of foreign literature)].
Piradov MA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):102-6. PubMed ID: 1664602
[No Abstract] [Full Text] [Related]
15. [Plasmapheresis as a method of intensive care in neurology].
Piradov MA
Anesteziol Reanimatol; 1996; (2):92-4. PubMed ID: 8754188
[No Abstract] [Full Text] [Related]
16. [Results of treatment with plasmapheresis in myasthenic crisis and severe polyneuropathy].
Usnarska-Zubkiewicz L; Bilińska M; Gruszka E
Pol Arch Med Wewn; 1991 Dec; 86(6):416-9. PubMed ID: 1819792
[TBL] [Abstract][Full Text] [Related]
17. Plasmapheresis combined with lymphocytapheresis and cytotoxic drugs as a therapeutic modality in neuroimmunological diseases.
Valbonesi M; Montani F; Florio G; Zerbi D; Beltramelli A
Ital J Neurol Sci; 1984 Mar; 5(1):35-40. PubMed ID: 6329999
[TBL] [Abstract][Full Text] [Related]
18. Development of facial palsy during immunoadsorption plasmapheresis in Miller Fisher syndrome: a clinical report of two cases.
Chida K; Takase S; Itoyama Y
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):399-401. PubMed ID: 9527160
[TBL] [Abstract][Full Text] [Related]
19. Prominent effect of immunoadsorption plasmapheresis therapy in a patient with chronic inflammatory demyelinating polyneuropathy associated with hepatitis B infection.
Inoue A; Oguchi K; Iwahashi T; Arakura H; Koh CS
Ther Apher; 1998 Nov; 2(4):305-7. PubMed ID: 10227761
[TBL] [Abstract][Full Text] [Related]
20. Treatment of myasthenia gravis with dropped head: a report of 2 cases and review of the literature.
Tamai M; Hashimoto T; Isobe T; Sato H; Doden T; Nakano T
Neuromuscul Disord; 2015 May; 25(5):429-31. PubMed ID: 25747003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
